| Financial Year |
March 31 2023 |
| Monetary Funds |
261,235,098.83 |
| Held-for-trading Financial Assets |
5,000,921.59 |
| Notes Receivable |
600,000.00 |
| Accounts Receivable |
161,680,123.55 |
| Advances to Suppliers |
8,030,080.55 |
| Other Receivables |
33,401,672.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
24,975,855.21 |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,781,692.03 |
| Total Current Assets |
474,729,588.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,146,385.09 |
| Long-term Equity Investment |
1,260,991,136.60 |
| Investment Properties |
-- |
| Fixed Assetes |
1,744,922.32 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
197,683,937.91 |
| R&D expenses |
4,594,152.81 |
| Goodwill |
1,364,299,800.16 |
| Long-Term Deferred and Prepaid Expenses |
4,398,847.20 |
| Deferred Income Tax Assets |
10,569,081.31 |
| Other Non-Current Assets |
541,439,260.00 |
| Sub-Total of Non-Current Assets |
3,491,371,664.56 |
| Total Assets |
3,966,101,253.36 |
| Short-Term Loans |
10,090,174.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
124,317,630.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,184,686.30 |
| Taxes Payable |
22,503,710.89 |
| Interest Payable |
1,016,635.03 |
| Dividend Payable |
-- |
| Other payables |
8,931,952.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,357,697.64 |
| Other Current Liabilities |
7,375,673.05 |
| Sub-Total of Current Liabilities |
292,445,821.88 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
198,920,800.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,712,430.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
238,494,675.60 |
| Total Liabilities |
530,940,497.48 |
| Paid-In Capital(Or Share Stock) |
73,892,895.00 |
| Capital Surplus |
1,612,253,007.12 |
| Surplus Reserve |
29,314,679.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,685,918,521.81 |
| Minority Stockholder's Interest |
17,582,798.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,417,577,957.66 |
| Owner's Equity（Stockholder's Equity） |
3,435,160,755.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,966,101,253.36 |
